Projects per year
Personal profile
Research area keywords
- Interstitial lung disease
Projects
- 10 Active
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
Glaspole, I. & Symons, K. M.
23/06/20 → 31/12/22
Project: Research
A randomized, double-blind, dose-ranging, placebo-controlled Phase 2a evaluation of the safety, tolerability and pharmacokinetics of PLN-74809 in participants with idiopathic pulmonary fibrosis.
Glaspole, I., Thien, F. & Symons, K. M.
1/05/20 → 31/12/21
Project: Research
A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis (ATLAS Study)
Glaspole, I. & Symons, K. M.
7/06/19 → 1/06/22
Project: Research
A Phase 3, randomized, double-blind, parallel-group, placebo controlled multicenter study to evaluate the efficacy and safety of two doses of GLPG1690 in addition to local standard of care for minimum 52 weeks in subjects with idiopathic pulmonary fibrosis.
Glaspole, I. & Symons, K. M.
7/06/19 → 1/12/22
Project: Research
Research Output
Ambulatory oxygen in fibrotic ILD: a pilot, randomised, triple-blinded, sham-controlled trial
Khor, Y. H., Holland, A. E., Goh, N. S. L., Miller, B., Vlahos, R., Bozinovski, S., Lahham, A., Glaspole, I. & McDonald, C. F., 27 Feb 2020, (Accepted/In press) In : Chest. 11 p.Research output: Contribution to journal › Article › Research › peer-review
Comprehensive pulmonary rehabilitation for interstitial lung disease: A consensus approach to identify core education topics
Holland, A. E., Watson, A. & Glaspole, I., Jun 2019, In : Patient Education and Counseling. 102, 6, p. 1125-1130 6 p.Research output: Contribution to journal › Article › Research › peer-review
3
Citations
(Scopus)
Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis
Nathan, S. D., Costabel, U., Glaspole, I., Glassberg, M. K., Lancaster, L. H., Lederer, D. J., Pereira, C. A., Trzaskoma, B., Morgenthien, E. A., Limb, S. L. & Wells, A. U., Apr 2019, In : Chest. 155, 4, p. 712-719 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
4
Citations
(Scopus)
Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing
Burgess, A., Goon, K., Brannan, J. D., Attia, J., Palazzi, K., Oldmeadow, C., Corte, T. J., Glaspole, I., Goh, N., Keir, G., Allan, H., Chapman, S., Cooper, W., Ellis, S., Hopkins, P., Moodley, Y., Reynolds, P., Zappala, C., Macansh, S. & Grainge, C., Oct 2019, In : Respirology. 24, 10, p. 988-995 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
2
Citations
(Scopus)
Exertional Desaturation and Prescription of Ambulatory Oxygen Therapy in Interstitial Lung Disease
Khor, Y. H., Goh, N. S., Glaspole, I., Holland, A. E. & McDonald, C. F., 1 Mar 2019, In : Respiratory care. 64, 3, p. 299-306 8 p.Research output: Contribution to journal › Article › Research › peer-review